During early pregnancy, the conceptus and mare communicate to establish pregnancy. Cell-secreted vesicles (e.g., exosomes) have been reported in serum. Exosomes contain bioactive materials, such as miRNA, that can mediate cell responses. We hypothesized that a) exosomes are present in mare circulation and quantity varies with pregnancy status, b) exosomes contain miRNAs unique to pregnancy status, and c) miRNAs target pathways in endometrium based upon pregnancy status of the mare. First, serum samples were obtained from mares in a crossover design, with each mare providing samples from a pregnant and nonmated control cycle (n ¼ 3/sample day) on Days 12, 14, 16, and 18 postovulation. Flow cytometry revealed the presence of serum microvesicles in mares in two different-sized populations (greater than or less than 100 nm), validated by transmission electron microscopy. Second, serum was collected on Days 9, 11, and 13 (n ¼ 4/day), and endometrial biopsies were collected on Days 11 and 13 (n ¼ 3/day) from pregnant and nonmated mares. Total RNA from serum exosomes was evaluated with quantitative RT-PCR using equine-specific miRNA sequences. A total of 12 miRNAs were found in different quantities on the specified days. Pathway analysis suggested that miRNAs targeted focal adhesion molecules (FAMs). Transcripts corresponding to FAMs were evaluated in endometrial biopsies. Protein levels and localization for PAK6 and RAF1 were further evaluated. Our data suggest that serum exosomes contain miRNA that differ based upon pregnancy status, and may affect mRNA expression related to focal adhesion pathway in the endometrium, with a potential role in maternal recognition of pregnancy.
INTRODUCTION
Maternal recognition of pregnancy (MRP) refers to the mechanism by which continued secretion of progesterone (P 4 ) by the corpus luteum (CL) ensures maintenance of pregnancy [1] . In nonpregnant mares on Day 14 postovulation, oxytocin is released from the endometrium and binds to endometrial receptors causing the release of more oxytocin and prostaglandin F 2a (PGF 2a ) [2] . In pregnant mares, the conceptus enters the uterus at Day 6 and, by Day 9, is surrounded by a glycoprotein capsule [3] . Uterine contractions move the embryo throughout the uterus, reaching its peak mobility between Days 11 and 14 [4, 5] . This mobility is necessary to attenuate the secretion of PGF 2a [4] . By Day 16, this mobility ceases; together, these factors indicate that MRP occurs between Days 11 and 14, and is antiluteolytic [4, 6, 7] .
The CL must be protected from endometrial PGF 2a in order to sustain P 4 production [8] [9] [10] . The physiological, morphological, immunological, and endocrinological changes that occur in the equine oviduct and uterus are vital to pregnancy success, yet differ from equivalent processes in other species [11] . PGF 2a functions as a luteolysin in mares, as in other large animals; however, the mechanism(s) of MRP in the horse is largely unknown [9, 12, 13] . It is known that if this signaling mechanism fails, so does MRP. One mechanism we propose in maternal-fetal communication involves exosomes-cell-secreted vesicles capable of transferring bioactive material, such as RNA and protein, from cell to cell [14] [15] [16] . Various techniques have been employed to study exosomes in pregnancy. Taylor et al. utilized protein levels in serum exosomes of women to detect differences in exosome quantities between normal and abnormal pregnancies, and nonpregnant women [17] . Redman and Sargent suggested the use of flow cytometry to detect a quantifiable difference in exosomes between pregnancy status in women [18] . We hypothesized that exosomes are present in mare serum, and their profile would differ with pregnancy status, potentially resulting in transcriptional changes in the endometrium. Our first aim was to identify exosomes in serum from pregnant and nonpregnant mares using flow cytometry and transmission electron microscopy (TEM). Second, we sought to determine the relative amount of exosomes in serum from pregnant and nonpregnant mares. Third, we examined the miRNA profile in exosomes isolated from serum of pregnant and nonpregnant mares. Finally, we determined potential pathways targeted by miRNAs and identified potential target genes in equine endometrium.
MATERIALS AND METHODS

Experiment 1. Exosome Presence in Equine Serum
Care and management of mares. Colorado State University (CSU) Institutional Animal Care and Use Committee (Approval No. 11-2795A) approved the use of all animals and experiments for this study. All procedures were approved and completed under the supervision of the University veterinarian. Quarter horse-type mares were utilized for this study, ranging from 8 to 15 yr in age, with a history of normal cyclicity. All mares were housed together in a dry lot and were provided free-choice alfalfa/grass hay mix. A simple crossover design was employed, with each mare serving as both a pregnant and nonpregnant (nonmated) control. Ovarian follicular development was monitored daily by transrectal ultrasonography to determine estrous cycle status. For the pregnant group, follicular development was monitored until an ovarian follicle of !35 mm in diameter was identified, after which mares were artificially inseminated every other day until ovulation was detected. Artificial insemination, with a minimum of 500 million progressively motile sperm from a single stallion of proven fertility, was used, and subsequent embryo presence was determined by transrectal ultrasonography at Days 12, 14, 16 , and 18 postovulation (according to the ovulation of each individual mare). Blood samples were collected via jugular venipuncture using BD Vacutainer tubes (BD, Franklin Lakes, NJ), with repeated collections on every sampling day until Day 18 (n ¼ 3 mares per day of treatment). Following blood collection on Day 18, embryos were collected by terminal uterine lavage. After embryo collection, the mare received a luteolytic dose of PGF 2a .
For samples from nonpregnant (nonmated) control mares, the subsequent estrous cycle was utilized. Transrectal ultrasonography was performed on a daily basis to determine the day of ovulation for mares that remained unmated. Blood samples were again obtained as described. Blood was also obtained from three additional mares (one Day 7 nonpregnant mare, one Day 12 pregnant mare, and one Day 43 pregnant mare), which were all pooled to provide a sample for preliminary experiments and a biological standard to establish flow cytometry settings for the main experiment. All blood samples were allowed to clot for 1 h at room temperature, after which they were centrifuged at 3000 3 g for 10 min at room temperature. Serum was removed, snap frozen in liquid nitrogen, and stored at À808C until analysis.
Exosome isolation from serum. Exosomes were isolated from serum samples using ExoQuick (System Biosciences, Inc., Palo Alto, CA). Serum was thawed on ice and samples were spun at 300 3 g for 10 min and 2000 3 g for 10 min to remove residual cells and debris. A final centrifugation of 10 000 3 g for 30 min was performed to remove microparticle contaminants, according to Théry et al. prior to exosome isolation [19] . After removal of contaminants, 400 ll was transferred to a 1.5-ml sterile microcentrifuge tube, after which 100 ll ExoQuick was added. Gentle inversion was performed to ensure proper mixing of serum and ExoQuick, which was then incubated at 48C overnight, per the manufacturer's instructions. Exosomes were pelleted following the incubation step with centrifugation at 1500 3 g for 30 min at room temperature. Supernatant was carefully removed and discarded. The resultant exosome pellet was resuspended in PBS (HyClone, Logan, UT) and processed for flow cytometry or TEM.
Flow cytometry. Exosome pellets were resuspended in 700 ll of 13 PBS (HyClone, Logan, UT). Resuspended samples were transported on ice to the Proteomics and Metabolomics Core Facility at CSU (Fort Collins, CO) for analysis by the MoFlo Flow Cytometer and High Speed Cell Sorter (Dako Colorado, Inc., Fort Collins, CO). Immediately prior to analysis by flow cytometry, samples were pipetted through a 50-lm filter to ensure that no large clumps were present to cause a blockage in the flow cell nozzle. Each filtered sample was split into two 300-ll aliquots in microcentrifuge tubes for analysis, which provided a duplicate for each exosome pellet. Counts of exosome events were obtained through gating on forward and side scatter along with the singleplatform approach using counting beads (CountBright absolute counting beads; Invitrogen, Carlsbad, CA) following the manufacturer's recommendations. Each 300-ll sample received 25 ll of CountBright absolute counting beads prior to analysis.
Multiple controls were utilized and included: a pooled serum exosome sample (from Day 12 and 43 pregnant and Day 7 nonpregnant mares), 13 PBS, 100-nm-sized standard beads, 13 PBS with 25 ll counting beads, and a pooled serum exosome sample with counting beads. Pooled serum exosome sample was used to determine the area of focus on the scatter plot and set the gates of analysis, while 13 PBS was used to determine background noise. Background was determined acceptable at 1% of events detected in the exosome gates set for analysis. Sized beads of 100 nm (PolySciences, Inc., Warrington, PA) provided a size standard detectable on scatter plot. Serial dilutions of sized beads were performed and the 2 3 10 9 /ml dilution was chosen for analysis. Summit V4.3 software (Dako Colorado, Inc., Fort Collins, CO) was utilized to analyze all flow cytometry data. Experimental design for the MoFlo involved analyzing controls first, followed by the pregnant and nonpregnant mare serumderived exosome samples. In addition, a wash step with sterile filtered water was employed after each sample was run to ensure that neither beads nor exosomes were sticking to the lines of the flow cytometer Statistical analysis. Analysis was performed on the absolute counts of exosome events detected in gates R4, R5, and R10 areas on the FACS scatter plot indicative of exosomes, calculated with CountBright bead formula. Analysis was performed between and within days of pregnancy using SAS 9.4 (SAS Institute Inc., Cary, NC). Repeated measures analysis was done using Proc Mixed. Both treatments (pregnant and nonpregnant) and day (12, 14, 16 , and 18) were within-subject factors. Fixed effects included treatment, day, and treatment by day. Random effects included horse and horse-by-treatment interaction. A Tukey-Kramer adjustment factor was also applied. Statistical significance was set at P 0.05.
Transmission electron microscopy. The pooled serum sample was utilized for TEM. Exosomes were isolated from serum with ExoQuick as described. Three samples from pooled serum were used to generate three exosome pellets. Exosome pellets were isolated and resuspended in 200 ll of 13 PBS (HyClone, Logan, UT). Resuspended pellets were transferred to the same 5-ml ultracentrifuge tube. After transfer, volume was increased to 5 ml with additional 13 PBS. Ultracentrifugation was performed at 100 000 3 g for 70 min to wash and remove ExoQuick and pellet the exosomes.
After ultracentrifugation, the supernatant was carefully removed with a gelloading tip. Pellet and remaining PBS were transferred to a 1.5-ml microcentrifuge tube with a normal pipet tip after 200 ll of 2% agar gel was added, taking care not to place it directly on the pellet. Centrifugation was performed at 17 500 3 g for 15 min to form a more visible exosome pellet. Supernatant was carefully removed and discarded, after which 50 ll of 2% agar was added to the pellet. Sample was placed on ice for 15 min to allow agar matrix to harden. Exosome pellet in agar matrix was removed from the tube with a spatula and excess matrix was sectioned. The resultant pellet was fixed in 2.5% glutaraldehyde in 5% sucrose, 0.1 M sodium cacodylate, pH 7.4, for 30 min and washed thrice in cacodylate buffer. This pellet was postfixed with 1% osmium tetroxide for 90 min, washed thrice in cacodylate buffer, dehydrated in a series of alcohols and propylene oxide, and embedded in Poly/bed 812. Thick (;1-lm thick) and thin (;80-nm thick) sections were cut on an ultramicrotome equipped with a diamond knife. Thick sections were prepared for light microscopy and thin sections for TEM. Thin sections collected on nickel grids and stained with uranyl acetate and lead citrate were examined using a JEOL 1200EX transmission electron microscope (JOEL Inc., Peabody, MA).
Experiment 2. Serum Exosome Content and Its Potential mRNA Targets in Equine Endometrium in Relation to Pregnancy Status
Experiment design and treatments. Mares were managed in the same manner as in Experiment 1. To evaluate serum exosome content, blood samples were collected on Days 9 (n ¼ 4), 11 (n ¼ 4), and 13 (n ¼ 4) as repeated measures via jugular venipuncture. All blood samples were allowed to clot for 1 h at room temperature, after which they were centrifuged at 3000 3 g for 10 min at room temperature. Serum was removed, snap frozen in liquid nitrogen, and stored at À808C until analysis. Endometrial biopsies were obtained on Days 11 (n ¼ 3) and 13 (n ¼ 3), split, and either immediately snap frozen in liquid nitrogen and stored at À808C until analysis or fixed for histological analysis via light microscopy. Embryos were collected via terminal uterine lavage on the same day as biopsy to confirm pregnancy. After embryo collection the mare received a luteolytic dose of PGF 2a . For the nonpregnant (nonmated) control, the subsequent estrous cycle was utilized. Endometrial biopsies to be fixed for histological analysis were placed in 4% paraformaldehyde (Affymetrix, Inc., Cleavland, OH) for 1 h at room temperature in a ratio of 1 part tissue to 10 parts fixative (1 mg/10 ml). The same tube was then moved to 48C overnight and transferred to 70% ethanol the next day until embedding. When all samples were collected, they were sent to the Colorado State Veterinary Diagnostics Laboratory (Fort Collins, CO) to be embedded in paraffin blocks.
RNA isolation and quantification. RNA isolation protocol varied based upon source of RNA. The first step of the experiment was to evaluate content of serum exosomes. Exosome isolation from serum was performed in the same manner as in Experiment 1. Total RNA (including miRNA) was isolated from the exosomes according to the manufacturer's protocols using TRI Reagent BD-RNA/DNA/Protein Isolation Reagent for Blood Derivatives (Molecular Research Center, Cincinnati, OH). Sample contents were lysed and separated by chloroform into RNA and protein layers. The RNA phase was transferred to a fresh tube, precipitated with isopropanol, and washed with 75% ethanol. All samples were treated with DNA-free DNase Treatment and Removal Reagent (Invitrogen) to minimize any DNA contamination.
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Total RNA was extracted from the endometrial biopsies using TRI Reagent RNA/DNA/Protein Isolation Reagent for Blood Derivatives (Molecular Research Center) for lysis and the RNeasy Mini Kit (Qiagen, Valencia, CA). Frozen tissue samples were homogenized in TRI Reagent and left to lyse at room temperature for 10 min. Chloroform was added for separation of RNA and protein layers. Protein layers were frozen at À808C until further analysis. The RNA phase was transferred to a new 1.7-ml tube and isolated using the Qiagen RNeasy Mini Kit (Qiagen) per the manufacturer's protocol. All samples were treated with an RNase-Free DNase set (Qiagen) to remove any DNA contamination. For both sets of RNA, quantification and purity was assessed using the Nanodrop Spectrophotometer ND-1000 (Thermo Scientific, Wilmington, DE) and 260/280 values above 1.7 were considered acceptable for PCR.
Real-time quantitative PCR. Two protocols were used to evaluate miRNA and mRNA expression values. For miRNAs in serum exosomes, cDNA was generated using miScript (Qiagen) per the manufacturer's protocol: 4 ll 53 miScript RT buffer, 1 ll reverse transcriptase mix, and 1 lg of RNA and water were used in a 20-ll solution and incubated for 60 min at 378C and then 5 min at 958C. The cDNA template was immediately added to quantitative RT-PCR (RT-qPCR) master mix for PCR analysis. A total of 346 equine miRNAspecific forward primers were used based on sequences obtained by an in silico detection model [20] . An additional well without primer served as a negative control. RT-qPCR was performed in 384-well plates. Each well contained 6 ll of total reaction including 2X QuantiTect SYBR Green PCR Master Mix, 103 miScript Universal reverse primer (Qiagen), and miRNA-specific forward primer and 0.1 ll of cDNA. RT-qPCR was performed using the LightCycler480 PCR system (Roche, Indianapolis, IN). Cycle conditions were 958C for 15 min, followed by 45 cycles of 948C for 15 sec for denaturation, annealing at 558C for 30 sec, and extension at 728C for 30 sec, ending in a melt curve analysis to confirm single cDNA amplification. Day 11 samples were analyzed using all 346 equine miRNAs. Based upon those results, a smaller subset of 83 equine miRNAs were used to analyze Days 9 and 13 (Supplemental Table S1 ; Supplemental Data are available online at www. biolreprod.org). The 83 miRNAs analyzed using samples from mares on Days 9 and 13 were found to be present in all samples regardless of pregnancy status on Day 11. The miRNAs were considered present at a quantitative cycle (Cp) value of less than 37. Amplicons were confirmed with analysis of appropriate amplification curves and melt peaks.
For analysis of mRNA content of endometrium, equine-specific forward and reverse primers were designed using Primer3web (http://bioinfo.ut.ee/ primer3/) with a product size between 115 and 135 bp, a primer length between 19 and 27 bp, a primer melting temperature between 608C and 658C, and a GC base pair nucleotide content between 40% and 60%. Primer lengths and sequences are listed in Supplemental Table S2 . Before PCR analysis, primer specificity was confirmed via DNA sequencing of the PCR products. PCR analysis was performed using an endometrial cDNA pool and GoTaq (Promega, Madison, WI) following the manufacturer's protocol. PCR products were run through gel electrophoresis to confirm size and presence of amplicon and each band was excised from gel for DNA isolation with Qiaquick Gel Extraction (Qiagen). Amplified DNA was sent to the University of California DNA Sequencing Facility (Davis, CA) for sequencing to confirm primer specificity.
After primer confirmation, PCR analysis of samples was performed. Total RNA was processed for reverse transcription using iScript cDNA Synthesis (Bio-Rad, Hercules, CA). Total RNA (1 lg) was added to each reverse transcription reaction with 4 ll of 53 iScript reaction mix, 1 ll of iScript reverse transcriptase, and nuclease-free water to reach a total reaction volume of 20 ll. Reverse transcription was performed following the manufacturer's specifications, with 5 min at 258C, 30 min at 428C, 5 min at 858C, and then holding at 48C for immediate use as cDNA template in RT-qPCR. For each real-time PCR reaction, 5 ll of SsoAdvanced SYBR Green Supermix (BioRad) was added to 2.5 ll of nuclease-free water, 1 ll of cDNA at a concentration of 50 ng/ll, and 1.5 ll of primer mix at a concentration of 10 lM, to reach a final volume of 10 ll. Samples were loaded into 384-well LightCycler 480 plates (Roche) and analyzed in duplicate using a LightCycler 480 PCR System (Roche). Real-Time PCR cycle conditions were set per the manufacturer's protocol: 30 sec at 958C, and 40 cycles of denaturing at 958C for 5 sec, and annealing and extension at 608C for 30 sec. PCR analysis followed by melt peak analysis occurring at 0.58C increments from 658C to 958C, holding for 2 sec at each increment. Genes were considered present at a Cp value of less than 37, and amplicons were confirmed with analysis of appropriate amplification curves and melt peaks.
Statistical analyses of real-time quantitative PCR. Differences between samples from pregnant and nonpregnant mares in RT-qPCR analysis of exosomal miRNA or endometrial mRNA were evaluated using the raw Cp values normalized to the geometric mean of eca-miR-99b, eca-miR-127, and eca-miR-129a-5p for miRNAs, or GAPDH, B2M, 18S and ACTB for mRNAs.
Relative expression was presented in the logarithmic scale to visualize all values. Analyses were done within and between days for the samples screened. Statistical analysis was conducted using SAS 9.4 (SAS Institute Inc.). Repeated measures analysis was performed using Proc Mixed with Tukey-Kramer adjustment applied for serum exosome samples and Proc Mixed with TukeyKramer adjustment applied for endometrial samples. Both treatments (pregnant and nonpregnant) and day (9, 11, and 13, or 11 and 13) are within-subject factors. Fixed effects included treatment, day, and treatment by day. Random effects included horse and horse-by-treatment interaction. Significance was assessed at P 0.05.
Pathway analysis. Potential targets of differentially expressed miRNAs were identified using Diana Labs mirPath, which is used to identify pathways of multiple miRNAs [21] . Although Diana Labs software does not include an ''equine'' option to search, the sequence for each equine miRNA was evaluated using Basic Local Alignment Search Tool from the National Center for Biotechnology Information to compare to human. Each equine miRNA was homologous to the human miRNA, ensuring that the search results were accurate for both human and equine miRNA. Top pathways are based on the negative natural log of an enrichment P value calculated from a modified Fisher exact test. After pathways were determined and target mRNAs were identified, genes of interest were evaluated with TargetScan (http://www.targetscan.org/ vert_71/) to ensure that seed regions for the miRNAs were present in the 3 0 untranslated region (UTR).
Protein isolation and quantification. Protein isolation and quantification protocols varied based upon the source of protein. Isolation from exosomes was completed per manufacturer's protocols using M-PER (Thermo Scientific). Briefly, exosomes were repelleted using centrifugation at 12 000 3 g for 30 min; 1 ml of M-Per reagent was used for cell lysis. Samples were mixed for 10 min and debris was pelleted by centrifugation at 16 000 3 g for 15 min. Protein concentrations were determined using the Bradford Assay technique from purified protein. Analysis was performed using a spectrophotometer at 595 nm and protein concentrations were determined based on a standard curve. Samples were stored at À808C until analysis.
For endometrial samples, the protein layer was thawed and purified per the manufacturer's protocol for TRI Reagent (Molecular Research Center). Protein was precipitated with acetone, washed with a series of centrifugation steps by adding 500 ll 0.3 M guanidine hydrochloride in 95% ethanol with 2.5% glycerol, storing at room temperature for 10 min, and centrifuging at 12 000 3 g for 5 min. Samples were solubilized in 8 M urea Tris-HCl (pH 8.0) and proteinase inhibitor cocktail and PMSF were added; protein from control (equine epididymal samples) was isolated in the same manner. Protein content in samples was quantified using the Pierce BCA Protein Assay Kit (Thermo Scientific) following the manufacturer's protocol. Standards were prepared using the manufacturer-provided BSA at 2.0 mg/ml. Working reagent utilizing manufacturer's reagents A and B was prepared. A microplate was loaded with 25 ll of standard or sample and 200 ll of working reagent, and was incubated at 378C for 30 min. Samples were quantified using the Synergy 2 Multi-Mode Microplate Reader (Biotek, Winooski, VT). Sample concentrations were determined based on a standard curve prepared with standards and stored at À808C until analysis.
Western blot analysis. Western blot analysis was used to identify the presence of HSP70 in serum exosome samples and controls due to its repeated prevalence in exosomes [22] . Therefore, HSP70 was used as an exosome marker for this experiment. Organelle-related proteins are not commonly found in exosomes due to their biogenesis within the endocytic pathway [23] . Therefore, cytochrome C was chosen as a negative control due to its presence on the external portion of mitochondria and the lack of mitochondria in exosomes. For Western blot analysis of HSP70, PAK6, and RAF1, a 12% 1.0-mm SDS-page polyacrylamide gel containing 1 M Tris-HCl pH 8.8, 30% Acrylamide Solution 37.5:1 (Bio-Rad), 10% SDS, TEMED (Bio-Rad), and 10% APS for the running gel and 1 M Tris-HCl pH 6.8, 30% Acrylamide Solution 37.5:1 (Bio-Rad), 10% SDS, TEMED (Bio-Rad), and 10% APS for the stacking gel was prepared. Due to the small size of cytochrome C (15 kDa), a Novex 4%-20% Tris-glycine 1.0 mm 10-well gel (ThermoFisher Scientific) was used to allow for better separation between bands. For HSP70 and cytochrome C analysis, 25 lg of protein was loaded into each well, while 20 lg was used for PAK6 and RAF1 analysis. Samples were incubated with buffer and DTT mix at 908C for 10 min. Samples were transferred into wells and run at 30 mA for 30 min and transferred to Protran nitrocellulose membranes (GE Healthcare Life Sciences, Pittsburgh, PA). Gels were transferred at 100 V for 60 min and membranes incubated in 5% blocking buffer for 1 h at room temperature (5% nonfat dried milk in TBST). Membranes were incubated with one of the following primary antibodies: anti-Hsp70 rabbit polyclonal (Abcam, San Francisco, CA) at a dilution of 1:200 in 5% milk TBST; anti-cytochrome C mouse monoclonal (Santa Cruz Biotechnology, Santa Cruz, CA) at a dilution of 1:200 in 5% milk TBST; anti-PAK6 rabbit polyclonal (Abcam) at a dilution of 1:500 in 5% milk TBST; or anti-RAF1 rabbit polyclonal (Abcam) at a dilution CIRCULATING miRNA AND EQUINE PREGNANCY of 1:1000 in 5% milk TBST overnight at 48C. The next day, membranes were washed three times with 13 TBST and incubated with horseradish peroxidaseconjugated goat polyclonal secondary antibody to rabbit IgG (Abcam) at a dilution of 1:2000 in 5% milk TBST for 1 h at room temperature. Membranes were again washed three times in 13 TBST for 5 min each and exposed to ECL Plus Western Blotting Detection Reagent (GE Healthcare Life Sciences) for 5 min and imaged for analysis on a Molecular Imager ChemiDoc XRSþ System (Bio-Rad).
Membranes that were initially exposed to anti-PAK6 and anti-RAF1 were washed and incubated with primary anti-bactin mouse monoclonal antibody (Santa Cruz Biotechnology) at a dilution of 1:1000 in 5% milk TBST for 2 h at room temperature. Membranes were washed three times in 13 TBST and incubated with horseradish peroxidase-conjugated goat polyclonal secondary antibody to mouse IgG (Abcam) at a dilution of 1:2000 in 5% milk TBST for 1 h at room temperature. Membranes were washed again in 13 TBST and exposed to ECL Plus Western Blotting Detection Reagent for 5 min and imaged for analysis on a Molecular Imager ChemiDoc XRSþ System. Each sample was analyzed in duplicate and normalized to b-actin. Statistical analysis was conducted using SAS 9.4 (SAS Institute Inc.). A Proc Mixed analysis with Tukey-Kramer adjustment applied for endometrial samples was performed. Both treatments (pregnant and nonpregnant) and day (11 and 13) are withinsubject factors. Fixed effects included treatment, day, and treatment by day. Random effects included horse and horse-by-treatment interaction. Significance was assessed at P 0.05.
Immunohistochemical analysis for PAK6 and RAF1. After samples were embedded in paraffin blocks, 5-lm sections were placed on a slide and incubated overnight at 378C. Slides were dewaxed and dehydrated using CitriSolve (Thermo Scientific) and an alcohol gradient. Antigen retrieval was performed by boiling samples in 10 mM sodium citrate, pH 6.0, for 20 min and leaving them in hot sodium citrate to cool for 1 h. Samples were washed in PBS for 10 min and blocked in 10% normal goat serum in PBS with 1% BSA at room temperature for 2 h. Samples were blotted dry and incubated in primary antibodies of anti-PAK6 rabbit polyclonal (Abcam) at a dilution of 1:100 in PBS with 1% BSA, anti-RAF1 rabbit polyclonal (Abcam) at a dilution of 1:100 in PBS with 1% BSA, or PBS with 1% BSA and no primary antibodies, to serve as a negative control, overnight at 48C in a humidity chamber. The next day, samples were washed in PBS for 10 min and incubated at room temperature in a humidity chamber with 0.3% H 2 O 2 in PBS for 15 min to suppress endogenous peroxidase activity and reduce background staining. Samples were then incubated with horseradish peroxidase-conjugated goat polyclonal secondary antibody to rabbit IgG (Abcam) at a dilution of 1:5000 in PBS with 1% BSA for 1 h in a humidity chamber at room temperature. They were rinsed in PBS three times for 5 min and ImmPACT DAB Peroxidase Substrate Solution (Vector Laboratories, Burlingame, CA) was applied for 10 min, per the manufacturer's instructions. To stop the color reaction, samples were rinsed in running water for 5 min and dehydrated again in an alcohol gradient. Once samples were dry, coverslips were mounted with cytoseal (Thermo Scientific).
RESULTS
Experiment 1. Exosome Preence in Equine Serum
Flow cytometry analysis. Results obtained from flow cytometry experiments revealed that the isolated vesicles were exosomes, as scatter profiles revealed greater than 90% of population events fell within the expected 100-nm size range (Fig. 1) . All samples analyzed contained this 100-nm size range scatter profile, while also exhibiting varying degrees of granularity or texture, as indicated by side scatter measurements. Counting bead recovery was consistently greater than 91.8%. Relative exosome amounts did not differ between pregnant and nonpregnant mares on Days 12, 14, 16, and 18 (P . 0.10). When comparing across days, there were also no differences detected (Fig. 2) .
Transmission micrographs microscopy analysis. Profiles obtained by TEM revealed similar sizes to those detected by flow cytometry, further confirming the identity of these vesicles as exosomes. Small variation in size and granularity of isolated exosomes was consistent with our findings by flow cytometry. A majority of vesicles were in the 100-nm size range, indicative of exosomes, in a pooled sample of serum exosomes from pregnant and nonpregnant mares (Fig. 3) . Additional vesicles were present both at larger size ranges, about 200 nm, and smaller sizes, about 50 nm (Fig. 3) .
Experiment 2. Serum Exosome Content and Their Potential mRNA Targets in Equine Endometrium in Relation to Pregnancy Status
Western blot analysis to confirm serum exosome population. Western blot analysis identified HSP70, a highly enriched protein in exosomes, in endometrium, epididymis, and serum exosome isolations (Fig. 4, A and B) . Cytochrome C was identified in endometrial and epididymal protein samples, but not in serum exosome protein samples (Fig. 4C ). This supported that the population used for this experiment included exosomes, and were void of substantial cell organelle contamination. Analysis of serum exosome content. RT-qPCR analysis on Day 11 exosome samples from pregnant and nonpregnant mares indicated that 83 miRNAs were present in samples from mares either during pregnant cycle, nonpregnant cycle, or both. These 83 miRNAs were used to profile serum exosomal miRNAs prior to MRP (Day 9) and during MRP (Days 11 and 13). On all days (9, 11, and 13) corresponding to before and during the period of MRP, there were exosomal miRNAs differentially present (P 0.05) relating to pregnancy status. On Day 9, four miRNAs were different between serum exosome samples from pregnant and nonpregnant mares (eca-miR-27a, eca-miR-29c, eca-miR-101, and eca-miR-486-5p), all of which were more abundant in samples from nonpregnant mares (Table 1, Fig. 5 ). Day 11 postovulation revealed two miRNAs that were differentially expressed. One miRNA, eca-miR-767-5p, was detected in greater quantity in samples from pregnant mares, and the other, eca-miR-195, was greater in samples from nonpregnant mares (Table 1, Fig. 6 ). On Day 13, six miRNAs were differentially expressed in serum CIRCULATING miRNA AND EQUINE PREGNANCY exosomal samples. Of these six samples, four (eca-miR-188-5p, eca-miR-653, eca-miR-874, and eca-miR-140-3p) were greater in samples from nonpregnant mares. The eca-miR-874 miRNA was only present in samples from nonpregnant mares. The other two miRNAs (eca-miR-30c and eca-miR-323-5p) were greater in samples from pregnant mares ( Table 1 , Fig. 7 ). Fold changes and P values for all differentially expressed miRNA are listed in Table 1 .
Across-day analysis for all miRNAs of differing quantities within days between pregnant and nonpregnant mares is presented in Figure 8 . While most miRNA content did not change across days in serum exosome samples from pregnant mares, most miRNA content was different between Days 9 and 11 and Days 11 and 13 in serum exosome samples from nonpregnant mares. Generally, across days, there was an increase in relative level of miRNAs on Day 11, which was followed by a relative decrease on Day 13.
DIANA mirPath analysis. Diana Labs mirPath for pathway analysis was performed in an attempt to identify potential pathway and gene targets of miRNAs on Days 9, 11, and 13. Some pathways on Day 9 included extracellular matrix (ECM)-receptor interaction, proteoglycans in cancer, and TGF-b signaling. On Day 11, pathways included signaling pathways regulating pluripotency of stem cells, fatty acid biosynthesis, and FoxO signaling. Day 13 miRNA potentially targeted pathways include glutamatergic synapse, regulation of actin cytoskeleton, and long-term potentiation. The miRNA present in all three days' samples had one pathway in common: focal adhesion pathway. Based upon these results, we decided to further evaluate focal adhesion molecules (FAMs) in equine endometrium and their presence based on pregnancy status during the period of MRP (Days 11 and 13) .
Analysis of FAMs in equine endometirum. Based upon pathway analysis, 61 genes were identified as potential target genes in the focal adhesion pathway associated with miRNAs in isolated serum exosomes from pregnant and nonpregnant mares (Supplemental Table S2 ). Primers were designed for these genes and used to evaluate their presence and expression pattern in equine endometrium on Days 11 and 13 in samples from both pregnant and nonpregnant mares. On Day 11, 10 genes were differentially expressed between endometrial CIRCULATING miRNA AND EQUINE PREGNANCY samples from pregnant and nonpregnant mares ( Table 2 , Fig.  9 ). Nine genes (RAF1, ITAG6, KDR, FIGF, PIK3CA, ITGBL1, LAMC1, THBS1, and ITGB8) had higher relative expression in samples from pregnant mares, while PAK6 was greater in samples from nonpregnant mares. On Day 13, six genes were differentially expressed (Table 2 , Fig. 10 ). Three (MET, BCL2, and ITGAV) were greater in samples from pregnant mares and three (AKT3, FIGF, and PAK6) were greater in samples from nonpregnant mares. Two (FIGF and PAK6) genes were differentially expressed between Days 11 and 13. PAK6 and RAF1 were chosen for further analysis.
Genes that were significantly different on one or both days were further analyzed across days within each treatment (pregnant and nonpregnant). Many expression patterns were observed for the different genes. One most notable pattern was for AKT3, FIGF, ITGB8, PIK3CA, and RAF1, which was best described as a reversal in abundance between Days 11 and 13 (Fig. 11) . It is also interesting to note that PAK6 was more abundant in endometrial samples from nonpregnant mares (P ¼ 0.057) on Day 13. All gene expression patterns can be found in Figure 11 . All significantly different genes for both days were evaluated with TargetScan to ensure that the seed region for a differentially expressed miRNA was present in the 3 0 UTR. All differentially expressed genes contained seed regions specific to significantly differentially expressed miRNAs.
Western blot analysis of PAK6 and RAF1 in equine endometrium. Western blot analysis of endometrium isolated from pregnant and nonpregnant mares was used to determine the specificity of polyclonal antibodies that were not raised specifically against equine peptide prior to immunohistochemical analysis, and for quantification purposes. Endometrial samples from Day 11 and 13 pregnant and nonpregnant mares were used. PAK6 had a predicted size of 75 kDa and was different in samples from pregnant and nonpregnant mares on both Days 11 and 13. On Day 11, there was more PAK6 in endometrial samples from pregnant mares (P ¼ 0.0009), but on Day 13 there was more PAK6 in endometrial samples from nonpregnant mares (P ¼ 0.0291, Fig. 12 ). Interestingly, Day 11 results are the opposite of mRNA results, but, by Day 13, both analyses indicated higher quantities in samples from nonpregnant mares. RAF1 was also analyzed and had a predicted size of 68 kDa. Protein quantity did not differ between samples.
Localization of PAK6 and RAF1 in equine endometrium. Immunohistochemical analysis was used to localize PAK6 and RAF1 in endometrial samples from pregnant and nonpregnant mares on Day 13 postovulation. Both proteins had similar localization patterns and did not vary based upon pregnancy status. PAK6 and RAF1 localized to the endometrial epithelium and the glandular cells in both pregnant and nonpregnant mares (Fig. 13) .
DISCUSSION
While many have evaluated MRP in the mare, none have evaluated the presence of exosomes and microvesicles in serum based upon the pregnancy status. We evaluated the presence of exosome serum, content of these exosomes in regard to pregnancy status, and the potential targeted pathways of miRNAs in exosomes. Western blot analysis revealed that ExoQuick was isolating a population of exosomes in endometrial, epididymal, and serum samples by identifying the presence of HSP70, which is highly enriched in exosomes, in these samples after exosomal isolation [22] . Additionally, CIRCULATING miRNA AND EQUINE PREGNANCY we confirmed cytochrome C, which is tightly associated with mitochondria and therefore separate from the endocytic pathway, in endometrium to be absent in serum exosome samples (Fig. 4) . These data, coupled with TEM, validate enrichment of a population of exosomes using ExoQuick.
Flow cytometry results indicated the presence of exosomes of variable granularity, albeit no difference in overall exosome amounts between pregnant and nonpregnant mares. TEM also revealed the presence of exosomes and other microvesicles. Currently, it is unclear whether these other vesicles comprise a new or different class of cell-secreted vesicles or reflect heterogeneity in exosome morphology.
Collectively, our results indicate no change in overall exosome amounts in pregnant and nonpregnant mare serum during Days 12-18 postovulation. Human syncytiotrophoblast cells produce and secrete exosomes, and can be detected in high amounts in late-term pregnant women [24] . It is possible that overall exosome amounts are quantitatively different later in pregnancy when endometrial cups form, or first attachment (Days ;38 to 80) occurs and formation of the placenta ensues due to the presence of more trophoblast cells [25] . Even though there is no difference in total amount, the content of these exosome populations warrant further study.
While we recognize that miRNAs are not exclusively packaged in exosomes, and that their presence in serum may be due to carrier proteins, we felt it important to assay their contents in regard to pregnancy status. RT-qPCR analysis identified 12 different miRNAs that are differentially expressed according to pregnancy status on Days 9, 11, or 13 postovulation. Of the 12 miRNAs that were differentially expressed, 9 were higher in exosome-enriched serum samples from nonpregnant mares. This suggests the importance of these exosomal miRNAs during MRP. It was noted that there was no miRNA that was consistently different between pregnant and nonpregnant mares. MRP is a complex process; therefore, it is not expected that a single miRNA is involved in this process; rather, a multitude of miRNAs is actively involved. Diana Labs miRPath was used to identify pathways regulated by the several different miRNAs that were identified to be differentially expressed.
A top-ranked pathway identified for all 3-day isolated exosomal miRNAs was FAMs. FAMs are macromolecular complexes usually comprised of heterodimeric transmembrane integrin receptors that regulate effects in extracellular matrices [26] . Vogel and Sheetz demonstrated that focal adhesions sense and transduce mechanical forces [27] . The transmission of force at cell adhesion sites affects pathways regulating growth, development, and proliferation. Mechanotransduction was also suggested previously by Rivera del Alamo et al., when intrauterine devices resulted in luteal persistence in mares [28] . We found FAMs targeted by non-pregnancy associated serum exosomal miRNAs, which suggests this pathway may be repressed in nonpregnant animals, but not repressed in pregnant mares. Burghardt et al. found a variety of differentially organized FAMs in endometrium, myometrium, subepithelial stroma, and maternal-conceptus interface in ovine pregnancy [26] . These FAMs appeared as a result of sensation of transduction of mechanical force from the presence of the elongating conceptus in the peri-implantation period. Maintenance of pregnancy in the mare is dependent upon the embryo moving from one uterine horn to the other many times per day, reaching the peak amount of times around Day 10 of pregnancy [4] . From this understanding of the embryo interacting with the endometrium, as well as the target of miRNAs in serum exosomes from nonpregnant mares, we suggest that embryo mobility may initiate signaling through FAMs, which are not repressed in pregnant animals. We hypothesize that FAMs may be involved in maintaining the CL in a luteotrophic, luteostatic, or anitluteolytic manner. Our understanding of what the embryo does when it interacts with the endometrium is limited, but pathway analysis reveals a number of genes that serum exosomal miRNAs could target in nonpregnant mares.
Using genes identified from pathway analysis, we evaluated the presence of 61 FAMs in equine endometrium based upon pregnancy status (Supplemental Table S2 ). All 61 mRNAs were present in endometrium, but 14 were differentially expressed based upon pregnancy status and/or day of pregnancy and the cycle. These 14 FAMs are categorized into three main functions within the pathway: kinases (RAF1, PAK6, PIK3CA, AKT3, and MET); integrins (ITGA6, ITGBL1, LAMC1, THBS1, ITGB8, and ITGAV); and cell regulators (KDR, FIGF, and BCL2). On Day 11, nine mRNAs were in greater abundance in samples from pregnant mares and one mRNA was in greater abundance in samples from nonpregnant mares. On Day 13, three mRNAs were in greater abundance in samples from pregnant mares and three mRNAs were in greater abundance in samples from nonpregnant mares. Two mRNAs, FIGF and PAK6, were differentially expressed on Days 11 and 13. FIGF (c-fos-induced growth factor) was more abundant in samples from pregnant mares on Day 11, and was more abundant in samples from nonpregnant mares on Day 13. In mice, FIGF mRNA is localized to the endothelial cells that line the vascular sinusoids in the uterus during implantation [29] . PAK6 (serine/threonine protein kinase 6/p21-activated kinase 6) was more abundant in samples from nonpregnant mares on Days 11 and 13. PAK6 has been evaluated in bovine uteri in relation to receptivity of the uterus to an embryo [30] . It was found that PAK6 is in greater abundance in uteri that are more receptive to an embryo and more conducive to a pregnancy [30] . RAF1 has been implicated in the migration rate of cells in the endometrium. In women, a higher abundance of RAF1 results in more cell migration into the endometrium [31] . Based upon these previous studies, we decided to further evaluate PAK6 and RAF1 in the endometrium.
Protein abundance was evaluated to determine if protein translation was occurring in the same pattern as mRNA abundance. PAK6 mRNA on Day 11 was more abundant in samples from nonpregnant mares, but protein expression was higher in samples from pregnant mares. On Day 13, both mRNA and protein expression levels were higher in samples from nonpregnant mares. This could indicate that cells on Day 11 are translating protein from the mRNA, leading to a higher abundance of protein and a lower abundance of mRNA expression in samples from pregnant mares, but on Day 13 there is less protein and less mRNA present in samples from pregnant mares (Fig. 12) . RAF1 had a different protein expression pattern compared to mRNA expression on both Days 11 and 13, but there was no quantity difference between samples from pregnant and nonpregnant mares, indicating that the protein may change location as the days progress (Fig. 12) .
Neither proteins' localization patterns varied based upon pregnancy status. They localized to the endometrial epithelium and glandular cells in both pregnant and nonpregnant mares (Fig. 13) .
FAMs play a crucial role in communicating signals at the interface between cells and ECM [32] . Through mechanosensory signaling, the ECM interacts with membrane-associated complexes that control many functions in the cell [33, 34] . It has also been shown that focal adhesion proteins are critical for successful implantation and placentation during early pregnancy in rodents [35] . Based on this information, we hypothesize that, in the mare, as the embryo is mobile throughout the entire uterus, it activates the focal adhesion pathway, leading to MRP. Although many different studies utilizing microarrays and transcriptomics have been completed evaluating equine endometrium in regard to MRP, this is the first study to identify specific FAMs in the endometrium [36] [37] [38] .
Further analysis of endometrial mRNAs predicted to be targeted by the exosomal-associated miRNAs from pregnant or nonpregnant mares may ultimately unveil the signal for MRP. Additionally, after further evaluation and experiments, these miRNAs may potentially reveal themselves as biomarker(s) for pregnancy or MRP.
Our results do not indicate the cell of origin of the isolated exosomes, as they can originate from any organ accessing the circulatory system. Additional research is needed to indicate cell of origin, providing valuable tools and insight into their involvement in the process of early pregnancy. For example, an in vivo endometrial explant culture system with equine embryo explants/secretions, as well as in vitro endometrial cell culture, could uncover the cell communication mechanism between the endometrium and conceptus, including specific markers that could be used to identify pregnancy-specific exosomes from the circulation.
In summary, our results indicate that exosomes and circulating miRNAs might play a role in early pregnancy in the mare. Exosomal miRNAs isolated from serum, which have a role in intercellular communication, may be directly indicative of the MRP signal, and could be used as biomarkers for MRP. Understanding MRP signaling could abrogate early embryonic loss and induce pseudopregnancy in horse herds with overpopulation problems, both of which are currently impossible. Our data indicate pathways, specifically targeting FAMs, matching physiological events in mares' pregnancies, namely embryo mobility. These exosomal miRNAs may be indicative of processes important in MRP and pregnancy CIRCULATING miRNA AND EQUINE PREGNANCY maintenance in the mare. This was the first study completed to evaluate serum exosome quantities in regard to pregnancy status, investigate the content of these exosomes, and identify potential targets in equine endometrium during MRP.
